Comparative Epigenomic Analysis of Murine and Human Adipogenesis  by Mikkelsen, Tarjei S. et al.
Comparative Epigenomic Analysis
of Murine and Human Adipogenesis
Tarjei S. Mikkelsen,1,4 Zhao Xu,1,2,4 Xiaolan Zhang,1 Li Wang,1 Jeffrey M. Gimble,3 Eric S. Lander,1 and Evan D. Rosen1,2,*
1Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA
2Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA
3Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Louisiana University System, 6400 Perkins Road, Baton Rouge,
LA 70808, USA
4These authors contributed equally to this work
*Correspondence: erosen@bidmc.harvard.edu
DOI 10.1016/j.cell.2010.09.006SUMMARY
We report the generation and comparative analysis
of genome-wide chromatin state maps, PPARg and
CTCF localization maps, and gene expression
profiles frommurine and humanmodels of adipogen-
esis. The data provide high-resolution views of
chromatin remodeling during cellular differentiation
and allow identification of thousands of putative
preadipocyte- and adipocyte-specific cis-regulatory
elements based on dynamic chromatin signatures.
We find that the specific locations of most such
elements differ between the two models, including
at orthologous loci with similar expression patterns.
Based on sequence analysis and reporter assays,
we show that these differences are determined, in
part, by evolutionary turnover of transcription factor
motifs in the genome sequences and that this turn-
over may be facilitated by the presence of multiple
distal regulatory elements at adipogenesis-depen-
dent loci. We also utilize the close relationship
between open chromatin marks and transcription
factor motifs to identify and validate PLZF and SRF
as regulators of adipogenesis.INTRODUCTION
Describing the gene regulatory networks (GRNs) that control
development, differentiation, and physiological processes is a
major goal of mammalian genome biology. A GRN consists of
trans-regulatory factors and cis-regulatory elements whose
interactions with each other and the environment govern the
expression of genes in the network and ultimately manifest as
a complex phenotype such as gastrulation, adipogenesis, or
glucose homeostasis (Arnone and Davidson, 1997). The core
trans-regulatory factors in a variety of GRNs have been identified
by expression profiling and genetic analysis, but the large size
and complex architecture of mammalian genomes have pre-
vented systematic identification of cis-regulatory elements.156 Cell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc.Recent advances in high-throughput DNA sequencing have
led to the development of new experimental tools that greatly
enhance our ability to study genome function. In particular,
chromatin immunoprecipitation and sequencing (ChIP-Seq)
allows efficient genome-wide profiling of transcription factor
(TF) localization (Johnson et al., 2007; Robertson et al., 2007)
and chromatin state (Barski et al., 2007; Mikkelsen et al.,
2007a). Because different classes of cis-regulatory elements
display characteristic chromatin signatures when they are active
(Hon et al., 2009), ChIP-Seq has emerged as a powerful tool for
comprehensive discovery of these elements.
Identifying the components of a GRN that govern a specific
phenotype of interest from ChIP-Seq maps of a given cell type,
however, remains challenging for several reasons. First, these
maps typically identify tens of thousands of putative regulatory
elements, only some of which are likely to be directly relevant
to the phenotype. Second, whereas these maps appear to be
highly sensitive, their specificity toward biologically relevant
elements is less clear (Birney et al., 2007). For example, TF local-
ization analyses frequently reveal many binding sites that have
no discernable effect on the expression levels of nearby genes
(Johnson et al., 2007; Robertson et al., 2007; Zhang et al.,
2005). Third, practical considerations often necessitate the use
of in vitro cell culture models that might be subject to aberrant
genetic or epigenetic changes. This raises the possibility that
some chromatin state components observed in an in vitro
model may not be representative of the analogous cell type
in vivo (Noer et al., 2009).
We reasoned that comparative profiling of multiple cell culture
models that display similar, inducible phenotypes might help
shed light on these issues. Profiling closely related cell types
before and after induction should help identify regulatory
elements that are directly related to the phenotype. Classifica-
tion of these elements as either model-specific or shared should
then provide a foundation for understanding their relative impor-
tance and therefore help prioritize in-depth functional studies.
To explore this approach, we focused on adipogenesis.
Adipocytes play a central role in systemic metabolism, coordi-
nating lipid and glucose homeostasis (Rosen and Spiegelman,
2006). The burgeoning human and financial costs of obesity,
type 2 diabetes, and other metabolic disorders have therefore
thrust adipocyte biology into the forefront of biomedical research
priorities (Camp et al., 2002). Adipogenesis is also one of the
most intensively studied examples of cellular differentiation,
and several cell culture models that appear to closely approxi-
mate events that occur during adipogenesis in vivo are available
(Rosen and MacDougald, 2006).
Here, we report the generation and analysis of genome-wide
chromatin state maps, TF localization maps, and gene expres-
sion profiles from multiple stages of differentiation in two
established models of adipogenesis, murine 3T3-L1 cells (L1s)
and human adipose stromal cells (hASCs). 3T3-L1 is a cell line
originally subcloned from embryonic fibroblasts (Green and
Meuth, 1974), and hASCs are primary cells derived from adult
subcutaneous lipoaspirates (Aust et al., 2004). Undifferentiated
L1s and hASCs (‘‘preadipocytes’’) have similar fibroblast-like
morphologies. When induced to undergo terminal differentiation
in adipogenic media, both change into round cells that exhibit
properties typical of adipocytes in vivo, such as insulin-stimu-
lated glucose uptake, lipogenesis, catecholamine-stimulated
lipolysis, and adipokine secretion. These two models therefore
provide the opportunity to study GRNs that govern similar
adipogenic phenotypes against a background of phylogenetic,
ontogenetic and technical differences.
RESULTS
Comparative Epigenomic Profiling of Adipogenesis
To facilitate comprehensive epigenomic profiling of cells under-
going adipogenesis, we expanded L1 and hASC preadipocytes
and induced differentiation in adipogenic media. We selected
four matched time points that represented similar stages of
differentiation, as judged by morphology and lipid droplet
accumulation. These time points corresponded to proliferating
(day 2) and confluent (day 0) preadipocytes, immature adipo-
cytes (day 2 for L1s, day 3 for hASCs), and mature adipocytes
(day 7 for L1s, day 9 for hASCs).
We generated genome-wide chromatin state maps using
ChIP-Seq, profiling six histone modifications (H3K4me3/me2/
me1, H3K27me3/ac, and H3K36me3) and the CCCTC-binding
factor (CTCF) at all four time points. We also profiled the adipo-
genic TF peroxisome proliferators-activated receptor g (PPARg)
at the last time point. The resulting data consist of 60 ChIP-Seq
experiments and two negative controls. We also measured
mRNA andmiRNA expression levels in bothmodels usingmicro-
arrays. All data have been deposited in public databases.
To visualize the data, we generated histograms of normalized
densities of ChIP fragments across the genomes. Figure 1 shows
these densities near the murine Pparg gene, which is strongly
upregulated during adipogenesis (Figure S1, available online,
shows the human PPARG locus). The profiled histone modifica-
tions and TFs showed spatial and temporal density distributions
that are qualitatively consistent with their known functions (Hon
et al., 2009). For example, H3K4me3, which is associated with
transcriptional initiation, was primarily found near known
promoters. A case in point is the gain of H3K4me3 observed
near the adipocyte-specific alternative promoter of Pparg (P2,
Figure 1). H3K4me2/me1 and H3K27ac, which are associated
with ‘‘open’’ chromatin and cis-regulatory activity, showed
dynamic distributions in promoter, intronic, and intergenicregions. H3K36me3, which is associated with transcriptional
elongation, was distributed across active gene bodies and
increased markedly across Pparg as it was upregulated.
H3K27me3, which is associated with Polycomb-mediated
repression, was distributed broadly across the inactive flanking
regions. The PPARg and CTCF densities showed sharp peaks,
consistent with individual TF binding sites.
To support quantitative analyses, we identified significant
clusters of ChIP fragments using a sliding window approach
for histone modifications and QuEST (Valouev et al., 2008) for
TF-binding sites. Each such region or binding site was assigned
an ‘‘enrichment score,’’ which represents the ratio of observed
over expected fragments. Their genome-wide distributions
are consistent with the qualitative patterns described above
(Table S1). mRNA and miRNA expression analyses revealed
correlated expression dynamics that are consistent with efficient
adipogenic differentiation (Figure S2, Table S2, and Extended
Experimental Procedures).
To compare data from the two models, we first attempted to
map each enriched region in the mouse genome to correspond-
ing regions of orthologous sequence in the human genome,
and vice versa, using previously computed whole-genome
alignments. About 80%–90% of these regions could be mapped
to the other genome. We then asked whether these orthologous
regions overlapped the same chromatin marks or TF-binding
sites in the other model (conservatively requiring an overlap
of R 1 bp). We will refer to such overlaps as ‘‘shared’’ marks
or binding sites and the remainder as ‘‘model-specific.’’
We conclude that the data provide a rich resource for studies of
chromatin remodeling and gene regulation in two key models of
adipogenesis. In the following sections, we focus on detection
and functional analysis of cis-regulatory elements in the adipo-
genic GRN and the sequence-specific TFs that interact with them.
HistoneModifications Associated with Distal Enhancers
We began our analysis by characterizing open chromatin marks
in regions distal to (>2 kb from) known promoters. H3K4me2/
me1 and H3K27ac were distributed in highly correlated patterns
at each time point and changed dynamically in thousands of
genomic regions in each cell culture model (Table S1). These
‘‘dynamic’’ regions were often clustered near genes with adipo-
genesis-dependent expression patterns, suggesting that they
represent cooperative or redundant distal enhancers. Ortholo-
gous genes with similar expression in L1s and hASCs frequently
showed similar chromatin marks, but the specific location of
these marks was often model specific; this suggests that the
expression pattern of genes is better conserved between the
models than the specific elements controlling the expression.
To identify putative distal enhancers, we focused on H3K27ac
because recruitment of histone acetyltransferases (HATs) is the
most specific signature known for these elements (Ghisletti
et al., 2010; Heintzman et al., 2009; Wang et al., 2008). We
detected 29,092 distal H3K27ac regions in L1 adipocytes
(day 7), with enrichment scores spanning an order of magnitude
(Table S3). Of these, 6096 (21%) showed aR 5-fold increase in
enrichment scores relative to preadipocytes (days 2 and 0),
suggesting that they harbor regulatory elements that recruit
HATs during adipogenesis. Conversely, we identified 5159Cell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc. 157
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Figure 1. Chromatin State and TF Localization Near Pparg during L1 Adipogenesis
Histograms of ChIP fragments across thePparg locus, normalized to fragments per 10million aligned reads, for each of the profiled histonemodifications and TFs
at four time points during L1 adipogenesis. All histograms are shown on the same scale, and high values were truncated as necessary. See also Figure S1 and
Figure S2 and Table S1 and Table S2.
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H3K27ac regions in L1 preadipocytes (day 2) whose enrich-
ment scores decreased at least 5-fold. We observed similar
dynamics in hASCs (Table S3).
Dynamic changes in open chromatin marks were significantly
correlated with changes in the expression levels of linked genes.
For simplicity, we assumed that each H3K27ac region was
associated with the closest known gene (although there are
counterexamples, as described below). Roughly 15% of all
genes on our microarrays showed aR 2-fold change in expres-
sion between L1 adipocytes and preadipocytes. We found that
the more the expression level of a gene increased or decreased,
the more likely it was to be associated with adipocyte- or prea-
dipocyte-specific H3K27ac, respectively (Figure 2A). Con-
versely, the likelihood that the expression level of a gene
changedR 2-fold was positively correlated with both the enrich-
ment scores (Figure 2B) and the total number (Figure 2C) of
dynamic H3K27ac regions associated with it. By contrast, asso-
ciation with invariant H3K27ac (enriched in both adipocytes and
preadipocytes) had little predictive value with respect to
changes in expression. We observed similar patterns in hASCs
(Figures 2D–2F). Distal regions that show changes in open chro-
matin marks during adipogenesis are therefore likely to be en-
riched for cell type-specific enhancers. Moreover, genes with
dynamic expression patterns appear to frequently be located
near multiple such enhancers (see below and Figure S3).
Comparing open chromatin marks between L1s and hASCs,
we found that 15%–30% of marks identified in one model
were shared with the other model (that is, orthologous se-
quences contained the same chromatin marks). Given that
regions enriched for each open chromatin mark only covered
2%–4% of each genome, this represents a highly significant
degree of overlap. Regions with the same size distributions
randomly placed across the two genomes would have an ex-
pected overlap of less than 0.5%. Nevertheless, the majority
(70%–85%) of distal open chromatin marks weremodel specific.
Orthologs that were only associated with dynamic open chro-
matin marks in one of the models often showed discordant
expression patterns. For example, orthologs whose expression
increased more in L1s than in hASCs were also more likely to
be associated with adipocyte-specific H3K27ac only in L1s
and vice versa (Figure 2G). This suggests that model-specific
open chromatin marks correlate with model-specific enhancers.
Of interest, orthologous genes with similar expression patterns
often had similar chromatin marks nearby, but the specific loca-
tions of these marks were typically model specific. For example,
at orthologous loci inducedR 2-fold in bothmodels, themajority
(84%) of adipocyte-specific H3K27ac regions in L1s were not
shared with hASCs and vice versa. Their expression patterns
therefore appear to be better conserved than the specific
enhancers that regulate them (below, we verify this observation
through functional analyses).
PPARg Localization
We next analyzed the distribution of binding sites for PPARg in
mature L1 and hASC adipocytes (day 7/9). PPARg is a nuclear
receptor that is recruited to PPAR response elements (PPREs)
during adipogenesis as a heterodimer with retinoid X receptors
(RXRs) (IJpenberg et al., 1997) and primarily functions as atranscriptional activator (Lefterova et al., 2008; Nielsen et al.,
2008). We found that PPARg was largely localized to distal
regions enriched for open chromatin marks. The vast majority
of PPARg-binding sites were not shared between L1s and
hASCs, and this could be explained, in part, by turnover of its
motif in the genome sequences. Loci with PPARg-binding sites
in both L1s and hASCs were, however, highly enriched for genes
with functions relevant to known adipocyte biology.
We detected 7,142 and 39,986 PPARg-binding sites in L1s
and hASCs, respectively (1% FDR; Table S4), with enrichment
scores spanning two orders of magnitude. The excess number
of human sites primarily reflects the identification of more
weak binding sites (Extended Experimental Procedures). Per-
forming ChIP-Seq with a different PPARg antibody yielded
similar results, and the L1 sites reported here showed good
concordance with 5299 sites previously detected in this model
using ChIP-chip (Lefterova et al., 2008; Figure S4).
The PPARg-binding sites followed qualitatively similar
patterns in L1s and hASCs, with the vast majority (85%–95%)
overlapping open chromatin marks (Figure 3A). Ab initio motif
discovery recovered motifs that were similar to the canonical
PPARg/RXR DR1 motif (Figure 3B). There are, however, 1.5
million instances of these motifs in each genome; this implies
that we detected PPARg binding at only 1 in 200 motifs in
the mouse genome. Other factors must therefore contribute to
binding site selectivity. Of note, a motif instance was 15 times
more likely be bound by PPARg in L1 adipocytes if it overlapped
a region enriched for open chromatin marks in preadipocytes
(pFisher < 10
60). In fact, 77% of all PPARg-binding sites de-
tected in L1s were located in such regions. This suggests that
PPARg recruitment during adipogenesis is strongly influenced
by the preadipocyte chromatin state.
The majority (79%) of sites bound by PPARg in L1s were not
shared with hASCs, despite the larger number of sites detected
in the latter model. Of note, 34% of L1 PPARg-binding sites that
could not be mapped to the human genome resided within
rodent-specific transposable element insertions, which implies
that they evolved after the mouse and human lineages
diverged. If an L1-binding site could be mapped to an ortholo-
gous human sequence, the presence of PPARg binding in
hASCs correlated with the presence a conserved motif and
open chromatin marks (Figure 3C). Evolutionary turnover of
DR1-like motifs is therefore likely to contribute to the differential
recruitment of PPARg and open chromatin marks between the
two models.
To explore the correlation between PPARg recruitment and
gene expression, we again assumed that each binding site
was associated with the closest known protein-coding gene.
We found that genes associated with PPARg in L1s were
approximately three times more likely than nonassociated genes
to be upregulatedR 2-fold (pFisher < 10
60). Themajority (84%) of
genes associated with PPARg-binding sites were not upregu-
lated, but the likelihood that a gene was upregulated increased
when an associated PPARg binding site had a higher ChIP
enrichment score; was shared with hASCs; or overlapped
adipocyte-specific H3K27ac (Figure 3D). The correlation
between upregulation and gain of H3K27ac is notable. It sug-
gests that, whereas PPARg binding is biased toward regionsCell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc. 159
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Figure 2. Histone Modifications and Distal cis-Regulatory Elements
(A) Fractions of genes associated with at least one adipocyte (Ad), preadipocyte (Pre), or invariant H3K27ac region in L1s, conditional on changes in expression
levels in adipocytes (max of days 2 and 7) relative to preadipocytes (max of days 2 and 0).
(B) Fractions of genes that showed R 2-fold upregulation (left) or downregulation (right) in L1s, conditional on the maximal enrichment score of associated
H3K27ac regions.
(C) Fractions of genes that showedR 2-fold upregulation (left) or downregulation (right) in L1s, conditional on the number of associated H3K27ac regions.
(D) Fractions of genes associated with at least one H3K27ac region in hASCs, conditional on their changes in expression levels in adipocytes (max [day 3/9])
relative to preadipocytes (max [day 2/0]).
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that were already acetylated in preadipocytes, PPARg-binding
sites that recruit HATs to new locations are more likely to be
functionally relevant.
Concentrating on genes with ‘‘dynamic’’ PPARg-binding sites
that gain H3K27ac in L1s, we found that those for which the or-
thologous human gene was not associated with H3K27ac in
hASCs were significantly more likely to show greater upregula-
tion in L1s than in hASCs and vice versa (pFisher < 10
4; Fig-
ure 3E). Model-specific PPREs are therefore likely to contribute
to differential gene regulation in the two models. Annotation
enrichment analysis (Dennis et al., 2003) revealed, however,
that genes that were associated with PPARg-binding sites and
upregulated in both models were strongly enriched for compo-
nents of the classic PPARg signaling pathway, as well as
essential adipocyte functions related to lipid metabolism and
cellular respiration (Figure 3F). Of note, only 57% of these
concordantly upregulated genes actually shared orthologous
PPARg-binding sites. Thus, PPARg targeting of adipocyte genes
appears to be better conserved than the specific PPREs that
mediate PPARg recruitment to these genes.CTCF Localization
We next analyzed the distribution of binding sites for CTCF, a
DNA-binding protein that plays a key role in higher-order organi-
zation of chromatin and is associated with insulator and
enhancer-blocking activities (Phillips and Corces, 2009). We
found that CTCF recruitment was relatively invariant during
differentiation in each model but that the specific binding sites
differed significantly between the twomodels. These differences
appear to be largely caused by evolutionary turnover of CTCF
motifs.
We detected43,000CTCF-binding sites at each time point in
each model (1% FDR). The sites followed largely intergenic
distributions similar to those described in other cell types (Barski
et al., 2007; Kim et al., 2007; Xi et al., 2007; Figure 3G). Ab initio
motif discovery recovered the known CTCF motif (Figure 3H),
and most (84%) binding sites overlapped a good match to
this motif. Less than half overlapped H3K27ac or H3K4 methyl-
ation, suggesting that these open chromatin marks are not
directly linked to CTCF localization. Most CTCF-binding sites
detected at one time point were also detected at other time
points. For example, 84% of CTCF-binding sites in mature L1
adipocytes were also bound in L1 preadipocytes.
In contrast, among the70% of binding sites in L1s that could
be mapped to orthologous regions in the human genome, only
about half (53%) were also bound in hASCs. Shared CTCF
binding in hASCs was strongly correlated with the presence
of a conserved CTCF motif in the human genome (Figure 3I).
As was the case for PPARg, among the remaining 30% of
CTCF-binding sites in L1s that could not be mapped, 65%,(E) Fractions of genes that showedR 2-fold upregulation (left) or downregulatio
H3K27ac regions.
(F) Fractions of genes that showedR 2-fold upregulation (left) or downregulation
(G) Fraction of genes associated with at least one adipocyte-specific H3K27ac r
levels during L1 and hASC adipogenesis.
See also Figure S3 and Table S3.including thousands of the most strongly enriched sites, were
located within rodent-specific transposon insertions.Functional and Comparative Analysis
of the Cd36/CD36 Locus
In the previous sections, we largely relied on genome-wide
statistical analysis. To explore the relationships between open
chromatin marks, TF localization, and cis-regulatory elements
in greater depth, we focused on the Cd36/CD36 locus. This
PPARg-responsive gene encodes a long-chain fatty acid
receptor expressed in adipocytes and other cell types (Yu
et al., 2003) and was one of the most strongly induced genes
in both L1s and hASCs. We confirmed the activity of multiple
adipocyte-specific promoters and enhancers predicted by the
L1 chromatin state maps using functional assays. Consistent
with our genome-wide results, comparative analysis revealed
that, whereas the Cd36/CD36 expression pattern is similar
between L1s and hASCs, several cis-regulatory elements active
in L1s are not conserved in the human genome.
We first analyzed the murineCd36 locus, which contains three
promoters (P1–P3, Figure 4A) and encodes five transcripts with
identical coding sequences. In preadipocytes, we detected
three CTCF-binding sites flanking the locus but little enrichment
for any of the histone modifications. In adipocytes, we detected
H3K4me3 at P2 and P3, suggesting that these are the major
promoters used in L1s. To confirm this, we quantified each
Cd36 isoform using RT-qPCR. As expected, the vast majority
(99%) of transcripts originated from P2 and P3 (Figure S5A).
We detected six adipocyte-specific H3K27ac regions across
a 150 kb region upstream of the two active promoters, five of
which also contained PPARg-binding sites. We also detected
broad adipocyte-specific enrichment of H3K4me2/me1 across
this upstream region.
To test whether the distal open chromatin marks identified
adipocyte-specific enhancers, we performed transient reporter
assays in L1 preadipocytes and adipocytes. We cloned 21
1 kb sequences that overlapped the six adipocyte-specific
H3K27ac regions, as well as most distal H3K4me2/me1 regions,
and 17 additional sequences without any ChIP enrichment as
negative controls (Table S5). Each cloned sequence was in-
serted into three different plasmids carrying a luciferase gene
downstream of P2, P3, or no promoter (114 distinct plasmids).
Plasmids with no promoter showed uniformly low reporter
expression, suggesting that the distal regions possess little
intrinsic promoter activity (Figure S5B). Plasmids with P2 or P3
showed reporter expression levels that were positively corre-
lated with the ChIP enrichment scores of the distal regions
from which they contained sequences (Figure S6). In particular,
sequences from six distinct regions (E1–E6) enhanced the
activity of P3R 2-fold in adipocytes (Figure 4B). Of note, thesen (right) in hASCs, conditional on the maximal enrichment score of associated
(right) in hASCs, conditional on the number of associated H3K27ac regions.
egion in L1s or hASCs, conditional on the ratio of their changes in expression
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Figure 3. PPARg and CTCF Localization in Adipocytes
(A) Summary of PPARg-binding sites in L1 and hASC adipocytes. For each quartile of ChIP enrichment scores, the columns show (from left to right) the
percentage of sites located% 2 kb from a known promoter; sites overlapping a PPARgmotif; sites overlapping H3K4me3/me2/me1 and/or H3K7ac in adipocytes
and in preadipocytes; sites that could be mapped to an orthologous region in the other genome; and mapped sites that were also bound by PPARg in the other
model.
(B) Motifs learned ab initio from sequences ± 100 bp from the top 800 PPARg-binding sites in L1s (ranked by enrichment scores). Virtually identical motifs were
learned from hASCs.
(C) Correlations between PPARg binding, the presence of a conserved motif instance, and open chromatin marks in human genomic regions orthologous to L1
PPARg-binding sites.
(D) Fractions of genes that were upregulatedR 2-fold in L1s or hASCs, conditional on association with a PPARg-binding site. Orthologous PPARg-binding sites
could be mapped to an orthologous region also bound in the other model. Dynamic PPARg-binding sites increased H3K27ac enrichmentR 5-fold.
(E) Fractions of genes that were upregulatedR 2-fold in L1s or hASCs, conditional on association with dynamic PPARg-binding sites.
(F) Annotation enrichment analysis of orthologs associated with PPARg-binding sites and upregulatedR 2-fold. p values are Benjamini corrected.
(G) Summary of CTCF-binding sites in L1 and hASC adipocytes.
(H) Motif learned ab initio from sequences ± 100 bp from the top 800 CTCF-binding sites in L1s (ranked by enrichment scores). A virtually identical motif was
learned from hASCs.
(I) Correlations between CTCF binding, the presence of a conserved motif instance, and open chromatin marks in human genomic regions orthologous to L1
CTCF-binding sites.
See also Figure S4 and Table S4.
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Figure 4. Identification of Adipocyte-Specific Cd36 cis-Regulatory Elements
(A) Chromatin state maps of the 300 kb Cd36/Gnat3 locus from L1 preadipocytes (day 2) and adipocytes (day 7). Cd36 has three known promoters (P1–P3).
(Asterisk) Start of the protein-coding sequence.
(B) Reporter assays. Each dot shows the ratio of normalized luciferase expression (RLU) from plasmids carrying distal fragments upstream of P2 or P3 over the
estimated basal activity of the promoter. Fragments from six distinct distal sites (E1–E6) showedR 2-fold mean enhancement of expression from P3 (orange
dots, top). Three of these (orange dots, bottom) also showedR 2-fold mean enhancement of expression from P2. E5 was present within two overlapping frag-
ments. Error bars show standard errors of the means.
(C) Chromosome conformation capture. Each dot shows the cross-linking frequency of a HindIII fragment to P3 (top) or P2 (bottom) in adipocytes relative to pre-
adipocytes. Error bars show standard errors of the means.
See also Figure S5, Figure S6, and Table S5.
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corresponded to five of the six distal adipocyte-specific
H3K27ac regions, whereas the sixth (E3) was primarily enriched
for H3K4me1. Sequences from E4–E6 also enhanced the activity
of P2R 2-fold in adipocytes. By contrast, only one plasmid (E5
upstream of P2) showed comparable enhancer activity in preadi-
pocytes. This confirms that dynamic H3K27ac enrichment is
a signature of cell type-specific enhancers.
To determine whether E1–E6 physically interact with P2 and
P3 in their native chromatin context (Ptashne, 1986), we used
chromosome conformation capture (Dekker et al., 2002). We
found that the frequency of interactions between the two
promoters and E3–E6, which are located 75–150 kb upstream,
increased 2-fold in adipocytes relative to preadipocytes
(Figure 4C and Table S5). E1 and E2, which are located much
closer to the promoters, also showed consistent but less-signif-
icant (1.1-fold) changes. We conclude that Cd36 is regulated
by multiple distal enhancers, including three that are located
within introns of the neighboring gene Gnat3.
We next compared the murine Cd36 locus to human CD36
(Figure 5A). All three murine promoters were conserved in the
human genome. In contrast to L1s, however, we only detected
H3K4me3 at P3, indicating that this is the major promoter used
in hASCs.
Three of the six enhancers identified in L1s (E2, E4, and E6)
were shared with hASCs. Of the three L1-specific enhancers,
E1 and E3 were located in nonrepetitive sequences in the mouse
genome but had no recognizable orthologs in human. Most of
the E5 sequence could be mapped, but the chromatin marks
across this 1 kb region in L1s were not shared with hASCs.
Upon close inspection, we found that the PPARg motif in E5 in
the mouse genome was located in a small (100 bp) fragment
of a rodent-specific LINE/L1 transposon (Figure 5B). Insertion
of this element therefore appears to have generated a species-
specific PPRE. Conversely, we detected at least two putative
enhancers/PPREs in hASCs (based on H3K27ac and PPARg
enrichment) that could not be mapped to the murine genome.
Two of the three distal CTCF-binding sites in L1s were also
shared with hASCs. The third site, located upstream of E6, could
be mapped to an orthologous region that was not bound in
hASCs (Figure 5C). CTCF did, however, bind to a site 5 kb
away in hASCs that was not sharedwith L1s. Inspection revealed
that the CTCF motif bound in L1s was not conserved in the
human genome and vice versa (Figure 5D). Thus, the approxi-
mate location of this putative insulator element appears to be
conserved even though the specific motif instances are not.
We conclude that, whereas the overall regulatory architecture
of theCd36/CD36 locus is conserved, there has been substantial
turnover of specific cis-regulatory elements.
Identification of Previously Unidentified
trans-Regulatory Factors
Finally, we explored whether we could use the chromatin state
maps to identify trans-regulatory factors in the adipogenic
GRN. L1s and hASCs each express hundreds of sequence-
specific TFs, not all of which are likely to be directly involved
in adipogenesis. Whereas our data show that many active
cis-regulatory elements are not shared, the identities and
sequence specificities of the factors that interact with them are164 Cell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc.likely to be better conserved (Weirauch and Hughes, 2010).
Accordingly, we enumerated instances of all known TF motifs
within regions that underwent chromatin remodeling in L1s or
hASCs and then ranked the motifs according to their relative
enrichment in adipocyte- or preadipocyte-specific regions.
Strikingly, many of the most enriched motifs from both models
corresponded to known pro- and anti-adipogenic regulatory
factors (Table S6).
Figure 6 shows the most enriched motifs in regions that (1)
gained or lost H3K27ac during L1 adipogenesis and (2) could
bemapped to orthologous regionswith the samemark in hASCs.
Each of these motifs was enriched in both the mouse and the
orthologous human sequence. Among the motifs most enriched
within adipocyte-specific H3K27ac regions are those recognized
by PPARg/RXR and C/EBP proteins, which together form the
core adipogenic GRN. The list of motifs also contained other
known regulators of adipogenesis, such as the IRF, GATA,
NF-kB, and STAT families. The motifs most enriched within
preadipocyte-specific H3K27ac regions are recognized by
several mediators of growth factor responses and regulators of
cell proliferation, such as AP-1 (FOS/JUN), SRF, and MEF2A,
as well as a variety of developmental factors from the homeodo-
main and POU families.
The presence of multiple known regulators near the top of the
ranked motif lists suggested that other TFs with similar ranks but
no previous evidence of involvement in adipogenesis are good
candidates for follow-up. We selected two of these factors
for further analysis: promyelocytic leukemia zinc finger protein
(PLZF, encoded by Zbtb16) and serum response factor (SRF,
encoded by Srf). Expression of both of these factors was de-
tected in our L1 and hASC microarray data. We also confirmed
their expression in mouse adipose tissue and differentiating L1
cells using RT-qPCR (Figure S7). To assess whether these
factors regulate adipogenesis, we used gain- and loss-of-func-
tion assays. We found that independent overexpression of either
factor in L1 cells (Figure S7) was sufficient to repress adipogen-
esis, as evidenced by reduced lipid accumulation (Figure 7A)
and diminished markers of terminal differentiation (Figures 7B
and 7C). Conversely, RNAi-mediated knockdown of PLZF or
SRF (Figure S7) enhanced L1 adipogenesis, as assessed by
the same parameters (Figures 7D–7F). Similar effects were
obtained with two unique hairpins for each factor. These data
indicate that trans-regulatory factors in GRNs can be identified
by an integrated approach incorporating epigenomic profiling
and motif enrichment analysis.
DISCUSSION
Wehave generated comparative chromatin statemaps, TF local-
ization maps, and gene expression profiles from differentiating
L1s and hASCs. Our initial analysis of the data demonstrates
their utility to studies of chromatin remodeling and gene regula-
tion in adipogenesis and cellular differentiation.
Comparisons between time points revealed a close correlation
between changes in gene expression and changes in distal
open chromatin marks. Whereas only a minority of regions
enriched for H3K27ac changed during adipogenesis, this
dynamic subset appeared to be highly enriched for adipocyte
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Figure 5. Comparison of Cd36/CD36 in L1 and hASC Adipocytes
(A) Genomic and chromatin state maps from L1 (top) and hASC (bottom) adipocytes. Orthology tracks show regions mapped from the mouse to the human
genome (pink) and vice versa (red). Gray vertical lines highlight orthologous sites, those terminated by X highlight sites that could not be mapped. Orange
dots show the E1–E6 enhancers identified in L1s.
(B) Expanded view of E5/E6 shows the locations of PPARg motifs (blue bars) and transposons (gray/black) in the genomic sequences. The PPARg motif
underlying the peak of the L1 ChIP-Seq signal lies within a rodent-specific LINE/L1 fragment (arrow).
(C) Expanded view of an upstream region shows CTCF ChIP-Seq signals at nonorthologous sites separated by 2.4–5 kb in L1s and hASCs.
(D) Alignments of the sequences underlying the two nonorthologous sites in (C) show that the underlying motifs (blue bars) are not conserved.
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Figure 6. TF Motifs Associated with Chro-
matin Remodeling during Adipogenesis
TF motifs with the highest relative enrichment in
adipocyte- (right) and preadipocyte-specific (left)
H3K27ac regions. The top 400 L1 adipocyte and
preadipocyte H3K27ac regions (ranked by enrich-
ment scores) that could be mapped to ortholo-
gous locations with H3K27ac in hASCs were
used. Each mammalian TRANSFAC (M prefix)
and UniPROBE (U prefix) motif was matched and
assigned adipocyte/preadipocyte enrichment
ratios in the underlying mouse and human
sequences (corrected for length and composition).
The ‘‘ratio’’ columns show the maximal (left) or
minimal (right) enrichment ratio from mouse and
human for nonredundant motifs with consistent
enrichment ratios in the two genomes. The ‘‘candi-
dates’’ columns show genes or gene families
expressed in L1 cells that are known to recognize
each of the motifs. See also Table S6.and preadipocyte-specific enhancers. Thus, profiling chromatin
states before and after induction of a phenotype of interest can
help pinpoint regulatory elements that are directly related to
that phenotype. Importantly, gain of histone acetylation might
help to distinguish functional PPREs from nonproductive
PPARg-binding sites. Similar observations were recently
reported for endotoxin- and androgen-responsive enhancers in
macrophages (Ghisletti et al., 2010) and prostate cancer cells
(He et al., 2010), respectively. We also found that dynamically
expressed genes were often associated with multiple distal
elements that showed coordinated changes in chromatin state.
Elucidating how these distinct elements interact with each other
and their target genes will be important to our understanding of
mammalian gene regulation.
Comparisons between the two models revealed significant
overlaps of chromatin marks in orthologous regions, which is
consistent with a previous study ofmouse and human fibroblasts
(Bernstein et al., 2005). The majority of open chromatin marks
and TF-binding sites were, however, not shared. Strikingly,
differential recruitment of PPARg and CTCF was correlated
with turnover of their motifs. This suggests that many model-
specific TF-binding sites and associated chromatinmarks reflect
genetic divergence between mouse and human, rather than
ontogenetic or technical differences between L1s and hASCs.
Similar turnover has recently been observed in hepatocytes166 Cell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc.(Odom et al., 2007; Schmidt et al.,
2010). Of interest, many TF-binding sites
that could not be mapped between the
genomes were located within lineage-
specific transposon insertions, which is
consistent with transposons being a
major creative force in the evolution of
mammalian gene regulation (Lowe et al.,
2007; Mikkelsen et al., 2007b). A key
remaining question is to what extent
turnover of TF-binding sites reflects
adaptation, or simply GRN ‘‘drift,’’ thatmay affect expression levels but has no significant biological
impact. Importantly, we found that orthologs targeted by PPARg
in both models were enriched for functions relevant to known
adipocyte biology. Moreover, analysis of the orthologous
Cd36/CD36 loci revealed multiple species-specific regulatory
elements, despite their similar expression patterns. The pres-
ence of multiple distal regulatory elements with similar activities
near a single genemight facilitate turnover of individual elements
by providing redundancy.
Finally, motif enrichment analysis revealed that the close
relationship between chromatin state and TF-binding sites can
be utilized to infer previously unidentified trans-regulators. We
previously identified roles for interferon regulatory factors
(IRFs) and the orphan nuclear receptor COUP-TFII in adipogen-
esis based on analysis of chromatin at a limited number of loci
(Eguchi et al., 2008; Xu et al., 2008). Using our genome-wide
data, we discovered two additional factors, PLZF and SRF,
with anti-adipogenic activity. PLZF is a member of the BTB/
POZ domain family of TFs (Kelly and Daniel, 2006) and appears
to function primarily as a repressor by recruiting nuclear receptor
corepressors (N-CoRs) and histone deacetylases (HDACs). SRF
is a MADS box TF originally named for its role in mediating the
effects of serum stimulation (Norman et al., 1988). We are
currently attempting to understand the specific functions of
PLZF and SRF in adipogenesis. In addition, we are using the
AB C
D
EV
Day 0
SRFPLZF
shSRFshPLZFshLuc
Day 8
C/EBPα
PPARγ
Adiponectin
Actin
Day 0 Day 4
Day 0 Day 8Day 4
C/EBPα
PPARγ
Adiponectin
Actin
FE
Adi poq
E
Cebpa
120
60
0 4 8
Day
0 4 8
Day
Pparg16
8
Adipoq Slc2a4
Dgat1 Fasn
300000
150000
18000
9000
16
8
6
3
R
el
 m
R
N
A
R
el
 m
R
N
A
R
el
 m
R
N
A
200
100
0 4 8
Day
0 4 8
Day
2000000
1000000
20
10
30000
15000
20
10
8
4
Cebpa Pparg
Adipoq Slc2a4
Dgat1 Fasn
R
el
 m
R
N
A
R
el
 m
R
N
A
R
el
 m
R
N
A
***
*** **
**
***
*** ***
***
***
***
***
***
***
***
*** ***
**
***
**
***
***
***
***
***
***
***
***
***
***
***
**
***
***
** *
**
***
***
***
***
**
***
***
***
**
*** ***
Day 4 Day 8
EV SRFPLZF EV SRFPLZF
Day 0 Day 4 Day 8
shSRFshPLZFshLuc shSRFshPLZFshLuc
EV
PLZF
SRF
shLuc
shPLZF
shSRF
sh
Lu
c
sh
PL
ZF
sh
SR
F
sh
Lu
c
sh
PL
ZF
sh
SR
F
sh
Lu
c
sh
PL
ZF
sh
SR
F
EV PL
ZF
SR
F
EV PL
ZF
SR
F
EV PL
ZF
SR
F
Figure 7. PLZF and SRF Regulate Adipogenesis
(A) L1 preadipocytes were transduced with retrovirus expressing PLZF or SRF (pMSCV empty vector [EV] as control) and induced to differentiate. The cells were
subjected to oil red O staining at the indicated time points.
(B) mRNA levels relative to 36B4 were assessed by RT-qPCR (mean ± SD; n = 4) at the indicated time points. **p < 0.01; ***p < 0.001.
(C) Protein levels were assessed by western blotting at the indicated time points.
(D) L1 preadipocytes were transduced with a retrovirus expressing control shRNA (shLuc), PLZF (shPLZF), or SRF (shSRF). The cells were subjected to oil red O
staining at the indicated time points.
(E) mRNA levels relative to 36B4 were assessed by RT-qPCR (mean ± SD; n = 4) at the indicated time points. *p < 0.05; **p < 0.01; ***p < 0.001.
(F) Protein levels were assessed by western blotting at the indicated time points. See also Figure S7.
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chromatin state maps to identify other factors in the adipogenic
GRN. This approach can be expected to become increasingly
powerful as the completeness and quality of TF motif databases
improve. More generally, we expect that it can be applied to
studies of a variety of other gene regulatory networks.
EXPERIMENTAL PROCEDURES
Oligonucleotides and Antibodies
All primers, hybridization probes, hairpin sequences, and antibodies used are
listed in Table S7 and the Extended Experimental Procedures.
Cell Culture
3T3-L1 cells were cultured and differentiated as described in Eguchi et al.
(2008). Human abdominal adipose tissue was obtained with informed consent
from a 33-year-old Caucasian female (BMI = 32.96 Kg/m2) undergoing lipoas-
piration (Pennington Biomedical Research Center Institutional Review Board,
Protocol PBRC24030). hASCs were isolated as described in Dubois et al.
(2008) and differentiated using a protocol modified from Hebert et al. (2009).
For additional details, see the Extended Experimental Procedures.
ChIP-Seq
L1 cells and hASCs were treated with 1% formaldehyde for 10min at 37C and
stored at 80C. ChIP and Illumina sequencing library construction were
performed as described in Mikkelsen et al. (2007a). The computational
analysis is described in the Extended Experimental Procedures.
RNA Preparation and Expression Analysis
Total RNA was prepared using TRIzol (Invitrogen). mRNA expression data
were generated using GeneChip arrays (Affymetrix). miRNA expression data
were generated using BeadChips (Illumina). RT-qPCR were performed using
SuperScript III (Invitrogen) or RETROscript kit (Ambion), SYBR Green, and
the 7900HT Real-Time PCR system (Applied Biosystems). Annotation
enrichment analysis was performed using DAVID 6.7 (Dennis et al., 2003).
Reporter Assays
Cd36 P2, P3, and 38 distal sequences were PCR amplified from a BAC (RP23-
175A11; BACPAC Resource Center) and cloned into pGL4.10 (Promega)
using In-Fusion (Clontech). L1 cells were nucleofected with solution SE (Lonza)
and the FF-150 and DS-137 programs for preadipocytes and adipocytes,
respectively. Luciferase activities were measured using Dual-Glow (Promega)
and an EnVision 2103 multilabel reader (PerkinElmer).
Chromosome Conformation Capture
Chromosome conformation capture (3C) was performed using RT-qPCR
with FAM/IBFQ hybridization probes (IDT) and HindIII digestion as described
in Hage`ge et al. (2007). The normalization library was generated from the
RP23-175A11 BAC.
Sequence Analysis
All sequence analyses were performed on the hg18 (human) andmm9 (mouse)
reference genome sequences and annotations (http://genome.ucsc.edu).
Orthologous regions were mapped using liftOver (UCSC), requiring > 10%
nucleotide overlap. Motif discovery was performed using MEME 4.3 (Bailey
and Elkan, 1994). Motif instance matching was performed using FIMO with
a p value threshold of 104. The motif enrichment analysis was performed
using TRANSFAC 11.3 and UniPROBE (Oct 7, 2009), as described in the
Extended Experimental Procedures.
PLZF and SRF Overexpression and Knockdown
ORFs were PCR amplified and cloned into pMSCV (Clontech). shRNAs
were synthesized and cloned into pSIREN (Clontech). Retroviruses were
generated using Phoenix cells and CellPhect (Amersham Biosciences) and
were used to transduce L1 preadipocyte subclones that typically differentiate
at 30%–50% efficiency. For additional details, see the Extended Experimental
Procedures.168 Cell 143, 156–169, October 1, 2010 ª2010 Elsevier Inc.ACCESSION NUMBERS
All microarray expression and sequencing data have been deposited to the
NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo/) under accession
number GSE20752.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and seven tables and can be found with this article online at doi:10.
1016/j.cell.2010.09.006.
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